Arrowstreet Capital, Limited Partnership Arrowhead Pharmaceuticals, Inc. Transaction History

Arrowstreet Capital, Limited Partnership

  • $114 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$20.56 - $63.12 $9.68 Million - $29.7 Million
-470,679 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$28.14 - $73.01 $13.2 Million - $34.4 Million
470,679 New
470,679 $29.9 Million
Q2 2019

Aug 14, 2019
SELL
$17.43 - $28.82 $3.76 Million - $6.21 Million
-215,536 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$12.05 - $20.18 $2.6 Million - $4.35 Million
215,536 New
215,536 $3.96 Million

Others Institutions Holding ARWR

# of Institutions
295
Shares Held
92.3M
Call Options Held
1.33M
Put Options Held
549K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email